The Effect of Linagliptin (BI 1356) on 24h-glucose Control and Various Biomarkers in Type 2 Diabetic Patients
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The objective of this study is to investigate the effect of BI 1356 on 24-h glucose control
and various pharmacodynamic parameters in type 2 diabetic patients with inadequate glycaemic
control.